Sonic Healthcare (SHL)

Simon Turner

Senior Equity Analyst

6 am October 15, 2020


Prior close: $35.50

A great Q1 thanks to COVID-19

The global pathology services provider Sonic Healthcare (ASX:SHL) released a trading update yesterday with its September quarter results.

Quarterly update

During the first quarter of the 2021 financial year, SHL’s revenues grew 29% to $2.14 billion and EBITDA increased 71% to $580 million. That is a very strong start to the year, considering the market was only forecasting 13% revenue growth and 15% EBITDA growth for the full year.

To read the full report … Become a Member or Login Here

Previous

Next

Register for our FREE reports here...

You have Successfully Subscribed!

Register for our FREE reports here...

You have Successfully Subscribed!